|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Summaries of Product Characteristics 31 - 60 of 365 |
|
|
Package leaflet | Status for supply | Name of the medicinal product |
|
|
European Medicines Agency's website: Tafinlar - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Taflotan 15 mikrog-ml silmätipat, liuos, kerta-annospakkaus SPC 2021-02-15
|
PL
|
Resepti
|
Taflotan sine 15 mikrog-ml silmätipat, liuos SPC 2023-06-16
|
PL
|
Resepti
|
Tafluprost Santen 15 mikrog-ml silmätipat, liuos SPC 2021-02-15
|
PL
|
Resepti
|
Tafluprost Santen 15 mikrogrammaa-ml silmätipat, liuos, kerta-annospakkaus SPC 2021-12-20
|
|
|
European Medicines Agency's website: Tagrisso - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Takhzyro - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Takipril 20 mg-ml injektioneste, liuos SPC 2020-10-26
|
|
|
European Medicines Agency's website: Talmanco - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Taltz - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: TALVEY - EMA: EPAR PI
Finnish Swedish
|
PL
|
|
Talzenna
|
|
|
European Medicines Agency's website: Talzenna - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Tambocor 10 mg-ml injektioneste, liuos SPC 2023-05-05
|
PL
|
Resepti
|
Tambocor 100 mg tabletti SPC 2021-10-01
|
PL
|
Resepti
|
Tambocor Retard 100 mg, 200 mg depotkapseli, kova SPC 2023-02-01
|
PL
|
Resepti
|
Tamictor 0.4 mg säädellysti vapauttava kapseli, kova SPC 2022-01-18
|
|
|
European Medicines Agency's website: Tamiflu - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Tamsact 0.4 mg säädellysti vapauttava kapseli SPC 2024 05-21
|
PL
|
Resepti
|
Tamsu-Anlini 0,4 mg säädellysti vapauttava kapseli, kova SPC 2022-06-28
|
PL
|
Resepti
|
Tamsucinfa 0,4 mg säädellysti vapauttava kapseli, kova SPC 2022-03-14
|
PL
|
Resepti
|
Tamsugaran 0.4 mg säädellysti vapauttava kapseli, kova SPC 2022-02-08
|
PL
|
Resepti
|
Tamsulogen 0,4 mg säädellysti vapauttava kapseli, kova SPC 2023-03-20
|
PL
|
Resepti
|
Tamsulosiinihydrokloridi Orion 0.4 mg depotkapseli, kova, SPC 2020-11-30
|
PL
|
Resepti
|
Tamsulosiinihydrokloridi Sandoz 0.4 mg säädellysti vapauttava kapseli, kova SPC 2021-07-09
|
PL
|
Resepti
|
Tamsumin 0.4 mg säädellysti vapauttava kapseli, kova SPC 2024-07-04
|
PL
|
Resepti
|
Tamsupli 0,4 mg säädellysti vapauttava kapseli, kova SPC 2022-03-14
|
PL
|
Resepti
|
Tamsurion 0.4 mg depotkapseli, kova SPC 2021-01-20
|
|
|
European Medicines Agency's website: Tandemact - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Tanonalla 5 mg / 2.5 mg, 10 mg / 5 mg, 20 mg / 10 mg, 30 mg / 15 mg, 40 mg / 20 mg depottabletti SPC 2024-08-16
|
|
| |